Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy

Oncology Letters

Volumn 4, Issue 1, 2012, Pages 151-155

  Hayashi, Jyunichi ^a   Sakata, Koh Ichi ^a   Someya, Masanori ^a   Matsumoto, Yoshihisa ^b   Satoh, Masaaki ^c   Nakata, Kensei ^a   Hori, Masakazu ^a   Takagi, Masaru ^a   Kondoh, Atsushi ^a   Himi, Tetsuo ^a   Hareyama, Masato ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c NTT CORPORATION   (Japan)

Author keywords

Hypopharyngeal cancer; Immunohistochemical staining; Ki 67; Ku70; Ku86; XRCC4

Indexed keywords

CISPLATIN; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; KI 67 ANTIGEN; KU ANTIGEN; XRCC4 PROTEIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DNA END JOINING REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; HYPOPHARYNX SQUAMOUS CELL CARCINOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; RADIATION DOSE; SQUAMOUS CELL CARCINOMA;

EID: 84861313431     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.674     Document Type: Article

References (21)

1. Adelstein DJ, Li Y, Adams GL, et al: An intergroup study phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98, 2003.
2. Denis F, Garaud P, Bardet E, et al: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22: 69-76, 2004.
3. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: 2091-2098, 2003.
4. Hall EJ: DNA strand breaks and chromosomal aberrations. In: Radiobiology for the Radiologist. Hall EJ and Giaccia AM (eds). 6th edition. Lippincott Williams & Wilkins, Philadelphia, pp16-29, 2006.
5. Polo SE and Jackson SP: Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modification. Gene Dev 25: 409-433, 2011.
6. Lees-Miller SP: The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight. Biochem Cell Biol 74: 503-512, 1996.
7. Jeggo PA: Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat Res 150: S80-S91, 1998.
8. Komuro Y, Watanabe T, Hosoi Y, et al: The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer 95: 1199-1205, 2002.
9. Zhao HJ, Hosoi Y, Miyachi H, et al: DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin Cancer Res 6: 1073-1078, 2000.
10. Sakata K, Matsumoto Y, Tauchi H, et al: Expression of genes involved in repair of DNA double-strand breaks in normal and tumor tissues. Int J Radiat Oncol Biol Phys 49: 161-167, 2001.
11. Kamdar RP and Matsumoto Y: Radiation-induced XRCC4 association with chromatin DNA analyzed by biochemical fractionation. J Radiat Res 51: 303-313, 2010.
12. Sakata K, Someya M, Nagakura H, et al: Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers. Jpn J Clin Oncol 38: 402-407, 2008.
13. Pointreau Y, Garaud P, Chapet S, et al: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101: 498-506, 2009.
14. Posner MR, Hershock DM, Blajman CR, et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. New Engl J Med 25: 1705-1715, 2007.
15. Someya M, Sakata K, Matsumoto Y, Satoh M, Narimatsu H and Hareyama M: Immunohistochemical analysis of Ku70/86 expression of breast cancer tissues. Oncol Rep 18: 1483-1487, 2007.
16. Hosoi Y, Watanabe T, Nakagawa K, et al: Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25: 461-468, 2004.
17. Raybaud-Diogene H, Fortin A, Morency R, Roy J, Monteil RA and Tetu B: Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 15: 1030-1038, 1997.
18. Okuno Y, Nishimura Y, Kashu I, Ono K and Hiraoka M: Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas. Br J Cancer 80: 387-395, 1999.
19. Nakano T and Oka K: Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer. Cancer 72: 2401-2408, 1993.
20. Burma S, Chen BPC and Chen DJ: Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair 5: 1042-1048, 2006.
21. Someya M, Sakata K, Matsumoto Y, et al: The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis 27: 117-122, 2006.